Evaluating the Feasibility of a Personalized Endpoint in Down Syndrome‐associated Alzheimer’s Disease: Inventory‐facilitated Goal Attainment Scaling

Abstract

Background: Evaluating health outcomes in Down syndrome‐associated Alzheimer’s disease (DS‐AD) is challenging due to variability in baseline function and cognition.

The paper